Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.
cytotoxicity
diabetes mellitus
essential oil
hot HPH
nanostructured lipid carriers (NLC)
sucupira oil
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
06 Feb 2020
06 Feb 2020
Historique:
received:
09
01
2020
revised:
30
01
2020
accepted:
02
02
2020
entrez:
12
2
2020
pubmed:
12
2
2020
medline:
20
11
2020
Statut:
epublish
Résumé
Essential oils are odorant liquid oily products consisting of a complex mixture of volatile compounds obtained from a plant raw material. They have been increasingly proven to act as potential natural agents in the treatment of several human conditions, including diabetes mellitus (DM). DM is a metabolic disorder characterized by chronic hyperglycemia closely related to carbohydrate, protein and fat metabolism disturbances. In order to explore novel approaches for the management of DM our group proposes the encapsulation of sucupira essential oil, obtained from the fruits of the Brazilian plants of the genus
Identifiants
pubmed: 32041134
pii: molecules25030685
doi: 10.3390/molecules25030685
pmc: PMC7038118
pii:
doi:
Substances chimiques
Drug Carriers
0
Excipients
0
Lipids
0
Oils, Volatile
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Curr Pharm Biotechnol. 2015;16(4):365-70
pubmed: 25658380
Pharmazie. 2006 May;61(5):431-7
pubmed: 16724541
Int J Pharm. 2018 Dec 20;553(1-2):428-440
pubmed: 30385373
J Microencapsul. 2005 Sep;22(6):581-92
pubmed: 16401575
Pharm Dev Technol. 2019 Dec;24(10):1243-1249
pubmed: 31437118
Prog Lipid Res. 2017 Oct;68:1-11
pubmed: 28778472
Molecules. 2019 Jul 24;24(15):
pubmed: 31344802
Nat Prod Res. 2019 Sep;33(18):2647-2654
pubmed: 29726697
Arthritis. 2015;2015:379459
pubmed: 26613051
J Aging Res. 2015;2015:682503
pubmed: 26346487
Int J Pharm. 2005 May 13;295(1-2):261-8
pubmed: 15848010
Pharm Dev Technol. 2018 Jan;23(1):96-105
pubmed: 28949267
Anal Chem. 2011 Oct 15;83(20):7947-54
pubmed: 21902214
Molecules. 2018 Dec 21;24(1):
pubmed: 30583476
Biomaterials. 2012 Jun;33(19):4889-906
pubmed: 22498300
Int J Pharm. 2018 Oct 5;549(1-2):261-270
pubmed: 30075252
Pharm Dev Technol. 2019 Jun;24(5):616-622
pubmed: 30477410
J Pharm Pharmacol. 2016 Sep;68(9):1093-108
pubmed: 27364922
Eur J Pharm Biopharm. 2014 May;87(1):1-18
pubmed: 24530885
Eur J Pharm Sci. 2013 May 13;49(2):175-86
pubmed: 23485439
Pharmaceutics. 2019 May 13;11(5):
pubmed: 31085997
J Control Release. 2017 Oct 28;264:247-275
pubmed: 28887133
Int J Mol Sci. 2019 Mar 15;20(6):
pubmed: 30875872
J Cosmet Sci. 2004 Sep-Oct;55(5):463-71
pubmed: 15608996
Polymers (Basel). 2019 Nov 19;11(11):
pubmed: 31752417
Saudi Pharm J. 2017 Feb;25(2):231-235
pubmed: 28344473
Int J Pharm. 2011 Nov 28;420(2):341-9
pubmed: 21907778
Colloids Surf B Biointerfaces. 2018 Nov 1;171:501-505
pubmed: 30081382
Pharm Dev Technol. 2019 Nov;24(9):1181-1185
pubmed: 31354002
Eur J Clin Pharmacol. 2011 Jul;67(7):653-61
pubmed: 21468743
Expert Rev Clin Pharmacol. 2019 Jan;12(1):1-7
pubmed: 30484336
Eur J Med Chem. 2013 Feb;60:249-53
pubmed: 23313633
Foods. 2018 Mar 01;7(3):
pubmed: 29494522
Phytother Res. 2018 Nov;32(11):2202-2213
pubmed: 30080294
Nanotechnology. 2011 Jan 28;22(4):045101
pubmed: 21169662
ACS Appl Mater Interfaces. 2017 May 24;9(20):16922-16932
pubmed: 28504886
Colloids Surf B Biointerfaces. 2010 Dec 1;81(2):412-21
pubmed: 20719479
Eur J Pharm Sci. 2012 Apr 11;45(5):613-23
pubmed: 22245538
Patient Prefer Adherence. 2018 Oct 05;12:1975-1987
pubmed: 30323567
Theranostics. 2018 Jan 1;8(2):464-485
pubmed: 29290821
J Appl Toxicol. 2014 Apr;34(4):395-403
pubmed: 24243595
Pharmaceuticals (Basel). 2019 Oct 10;12(4):
pubmed: 31658729
Mater Sci Eng C Mater Biol Appl. 2012 Aug 1;32(6):1375-9
pubmed: 24364934
Pharmaceutics. 2019 Jul 24;11(8):
pubmed: 31344882
Eur J Pharm Sci. 2017 Jan 1;96:53-61
pubmed: 27613382
Handb Exp Pharmacol. 2010;(197):115-41
pubmed: 20217528
J Clin Med. 2019 Aug 28;8(9):
pubmed: 31466386
Biotechnol Adv. 2013 Sep-Oct;31(5):514-23
pubmed: 22940401
Int J Pharm. 2018 Sep 5;548(1):217-226
pubmed: 29966744
Colloids Surf B Biointerfaces. 2011 Aug 1;86(1):125-30
pubmed: 21543196
Colloids Surf B Biointerfaces. 2014 Nov 1;123:916-23
pubmed: 25466464
J Pharm Sci. 2012 Feb;101(2):707-25
pubmed: 22012873
J Microencapsul. 2006 Jun;23(4):377-88
pubmed: 16854814
J Chromatogr A. 2013 Aug 30;1305:276-84
pubmed: 23890548
J Microencapsul. 2006 Jun;23(4):417-33
pubmed: 16854817
Molecules. 2019 Nov 20;24(23):
pubmed: 31756981
Eur J Pharmacol. 2017 Jun 5;804:68-77
pubmed: 28322839
Antioxidants (Basel). 2019 Aug 03;8(8):
pubmed: 31382599
Int J Pharm. 2015 Apr 10;483(1-2):220-43
pubmed: 25683145
Eur J Pharm Biopharm. 2016 Nov;108:235-252
pubmed: 27519829
Science. 1967 Aug 25;157(3791):950-1
pubmed: 5006418
J Drug Deliv. 2012;2012:750891
pubmed: 22175030
Mol Aspects Med. 2015 Dec;46:21-33
pubmed: 26549348
Colloids Surf B Biointerfaces. 2012 Dec 1;100:84-9
pubmed: 22766285
Eur J Med Chem. 2014 Jun 23;81:28-34
pubmed: 24819957